Moreover, in mouse xenograft models of human cancers, such as pancreatic cancer and multiple myeloma, the pharmacological inhibition of PERK by compound GSK2656157 led to decreased vascular density, altered amino acid metabolism, and reduced tumor growth [141]. Here, EIF2AK3 is linked to neoplasm.